AbbVie Inc. Stock price

Equities

ABBV

US00287Y1091

Pharmaceuticals

Market Closed - Nyse 04:00:02 2023-11-29 pm EST Intraday chart for AbbVie Inc. 5-day change 1st Jan Change
138.50 USD +0.30% +0.02% -14.30%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site
Sales 2023 * 53.90 B Sales 2024 * 53.27 B Capitalization 244 B
Net income 2023 * 8,765 M Net income 2024 * 10.83 B EV / Sales 2023 *
5,37x
Net Debt 2023 * 45.52 B Net Debt 2024 * 38.88 B EV / Sales 2024 *
5,31x
P/E ratio 2023 *
26,3x
P/E ratio 2024 *
21,2x
Employees 50,000
Yield 2023 *
4,32%
Yield 2024 *
4,50%
Free-Float 96.74%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.55%
1 week+0.14%
Current month-1.78%
1 month-2.27%
3 months-6.04%
6 months+1.63%
Current year-14.19%
More quotes
1 week
137.65
Extreme 137.65
140.08
1 month
135.85
Extreme 135.85
145.71
Current year
130.96
Extreme 130.9601
168.11
1 year
130.96
Extreme 130.9601
168.11
3 years
101.55
Extreme 101.5478
175.91
5 years
62.55
Extreme 62.55
175.91
10 years
45.45
Extreme 45.45
175.91
More quotes
Managers TitleAgeSince
Chief Executive Officer 69 2012
Director of Finance/CFO 56 2012
President 52 2011
Members of the board TitleAgeSince
Director/Board Member 62 2012
Director/Board Member 65 2012
Director/Board Member 69 2012
More insiders
Date Price Change Volume
23-11-29 138.50 +0.30% 3 987 938
23-11-28 138.08 -0.73% 5,347,231
23-11-27 139.09 +0.30% 5,529,373
23-11-24 138.67 +0.14% 1,636,535
23-11-22 138.47 -0.19% 3,428,670

Delayed Quote Nyse, November 29, 2023 at 12:36 pm EST

More quotes
AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (78.7%), Germany (2.3%), Canada (2%), Japan (1.6%), China (1.6%), France (1.4%), Australia (0.9%), Spain (0.9%), the United Kingdom (0.8%), Italy (0.8%), Brazil (0.7%) and other (8.3%).
Calendar
More about the company
Trading Rating :
Investor Rating :
ESG Refinitiv :
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
138.08USD
Average target price
167.21USD
Spread / Average Target
+21.09%
Consensus
1st Jan change Capi. (M$)
-14.19% 244 B $
+61.82% 532 B $
+46.99% 452 B $
-14.09% 365 B $
-9.29% 254 B $
-18.62% 216 B $
+1.50% 200 B $
-10.57% 195 B $
-41.38% 168 B $
-5.53% 118 B $
Other Pharmaceuticals
  1. Stock
  2. Equities
  3. Stock AbbVie Inc. - Nyse
-40% off Black Friday : Our subscriptions help you unlock the best investment opportunities.
Enjoy this offer